Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-25-000077
Filing Date
2025-08-04
Accepted
2025-08-04 07:04:06
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20250630.htm   iXBRL 10-Q 1256117
2 EX-31.1 a2q25krysex311.htm EX-31.1 11472
3 EX-31.2 a2q25krysex312.htm EX-31.2 11469
4 EX-32.1 a2q25krysex321.htm EX-32.1 10949
  Complete submission text file 0001711279-25-000077.txt   6334618

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20250630.xsd EX-101.SCH 37000
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20250630_cal.xml EX-101.CAL 66496
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20250630_def.xml EX-101.DEF 162361
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20250630_lab.xml EX-101.LAB 543678
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20250630_pre.xml EX-101.PRE 354047
67 EXTRACTED XBRL INSTANCE DOCUMENT krys-20250630_htm.xml XML 1000236
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 251177961
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)